PUBLISHER: QYResearch | PRODUCT CODE: 1170016
PUBLISHER: QYResearch | PRODUCT CODE: 1170016
In 2021, the Global Human Milk Oligosaccharides (HMO) market size was valued at USD 378.52 Million, increased from USD 83.73 Million in 2017, and the market is forecasted to reach USD 1055.83 Million by 2028, growing at CAGR of 14.54% between 2022 and 2028.
The global main manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), ZuChem, etc. In 2021, the global top 3 largest players have a share approximately 80.96% in terms of revenue.
The global Human Milk Oligosaccharides (HMO) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides (HMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.